Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 631329, 6 pages
http://dx.doi.org/10.1155/2015/631329
Research Article

In Vitro Evaluation of the Effects of Eurycoma longifolia Extract on CYP-Mediated Drug Metabolism

Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do 426-791, Republic of Korea

Received 27 April 2015; Revised 18 June 2015; Accepted 21 June 2015

Academic Editor: Siew Hua Gan

Copyright © 2015 Young Min Han et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. B. S. Kardono, C. K. Angerhofer, S. Tsauri, K. Padmawinata, J. M. Pezzuto, and A. D. Kinghorn, “Cytotoxic and antimalarial constituents of the roots of Eurycoma longifolia,” Journal of Natural Products, vol. 54, no. 5, pp. 1360–1367, 1991. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Morita, E. Kishi, K. Takeya, H. Itokawa, and O. Tanaka, “New quassinoids from the roots of Eurycoma longifolia,” Chemistry Letters, vol. 19, no. 5, pp. 749–752, 1990. View at Google Scholar
  3. K. Mitsunaga, K. Koike, T. Tanaka et al., “Canthin-6-one alkaloids from Eurycoma longifolia,” Phytochemistry, vol. 35, no. 3, pp. 799–802, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Itokawa, E. Kishi, H. Morita, K. Takeya, and Y. Iitaka, “Eurylene, a new squalene-type triterpene from Eurycoma longifolia,” Tetrahedron Letters, vol. 32, no. 15, pp. 1803–1804, 1991. View at Publisher · View at Google Scholar · View at Scopus
  5. P.-C. Kuo, L.-S. Shi, A. G. Damu et al., “Cytotoxic and antimalarial β-carboline alkaloids from the roots of Eurycoma longifolia,” Journal of Natural Products, vol. 66, no. 10, pp. 1324–1327, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Bhat and A. A. Karim, “Tongkat Ali (Eurycoma longifolia Jack): a review on its ethnobotany and pharmacological importance,” Fitoterapia, vol. 81, no. 7, pp. 669–679, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. H. H. Ang, K. L. Chan, and J. W. Mak, “In vitro antimalarial activity of quassinoids from Eurycoma longifolia against Malaysian chloroquine-resistant Plasmodium falciparum isolates,” Planta Medica, vol. 61, no. 2, pp. 177–178, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. C. P. Varghese, C. Ambrose, S. C. Jin, and Y. J. Lim, “Antioxidant and anti-inflammatory activity of Eurycoma longifolia Jack, a traditional medicinal plant in Malaysia,” International Journal of Pharmaceutical Sciences and Nanotechnology, vol. 5, no. 4, pp. 1875–1878, 2013. View at Google Scholar
  9. K. L. Chan, M. J. O'Neill, J. D. Phillipson, and D. C. Warhurst, “Plants as sources of antimalarial drugs. Part 31 Eurycoma longifolia,” Planta Medica, vol. 52, no. 2, pp. 105–107, 1986. View at Google Scholar · View at Scopus
  10. S. Hamzah and A. Yusof, “The ergogenic effects of Tongkat Ali (Eurycoma longifolia),” British Journal of Sports Medicine, vol. 37, pp. 465–466, 2003. View at Google Scholar
  11. P. Zanoli, M. Zavatti, C. Montanari, and M. Baraldi, “Influence of Eurycoma longifolia on the copulatory activity of sexually sluggish and impotent male rats,” Journal of Ethnopharmacology, vol. 126, no. 2, pp. 308–313, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. P. K. Mukherjee and A. Wahile, “Integrated approaches towards drug development from Ayurveda and other Indian system of medicines,” Journal of Ethnopharmacology, vol. 103, no. 1, pp. 25–35, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. U. Rehman, M. S. Choi, K. Choe, and H. H. Yoo, “Interactions between herbs and antidiabetics: an overview of the mechanisms, evidence, importance, and management,” Archives of Pharmacal Research, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Ramasamy, L. V. Kiew, and L. Y. Chung, “Inhibition of human cytochrome P450 enzymes by Bacopa monnieri standardized extract and constituents,” Molecules, vol. 19, no. 2, pp. 2588–2601, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. M. Han, M. Jang, I. S. Kim, S. H. Kim, and H. H. Yoo, “Simultaneous quantitation of six major quassinoids in Tongkat Ali dietary supplements by liquid chromatography with tandem mass spectrometry,” Journal of Separation Science, 2015. View at Publisher · View at Google Scholar
  16. C.-H. Teh, V. Murugaiyah, and K.-L. Chan, “Developing a validated liquid chromatography-mass spectrometric method for the simultaneous analysis of five bioactive quassinoid markers for the standardization of manufactured batches of Eurycoma longifolia Jack extract as antimalarial medicaments,” Journal of Chromatography A, vol. 1218, no. 14, pp. 1861–1877, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Pan, K. H. Tiong, B. A. Abd-Rashid et al., “Effect of eurycomanone on cytochrome P450 isoforms CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 in vitro,” Journal of Natural Medicines, vol. 68, no. 2, pp. 402–406, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Zhao, Y.-Q. He, J. Wang, K.-M. Ding, C.-H. Wang, and Z.-T. Wang, “Inhibition of human cytochrome P450 enzymes 3A4 and 2D6 by β-carboline alkaloids, harmine derivatives,” Phytotherapy Research, vol. 25, no. 11, pp. 1671–1677, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. S. A. B. Salman, S. Amrah, M. S. A. Wahab et al., “Modification of propranolol's bioavailability by Eurycoma longifolia water-based extract,” Journal of Clinical Pharmacy and Therapeutics, vol. 35, no. 6, pp. 691–696, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Purwantiningsih, A. H. J. Hussin, and K. L. Chan, “Herb-drug interaction studies of Eurycoma longifolia extract TAF-273 on the metabolism of rosiglitazone, an antidiabetic drug,” Asian Journal of Pharmaceutical and Clinical Research, vol. 4, no. 2, pp. 88–92, 2011. View at Google Scholar · View at Scopus